For about 25 years of untiring research, a potential vaccine for Type 1 Diabetes developed in Finland is already set for human clinical trials.
The latest development comes amid the increasing numbers of people suffering the disease, in fact, in the United States, it is estimated that in 2050 about 5 million people will be diagnosed with Type 1 Diabetes (T1D).
To explain the nature of the disease, T1D is a autoimmune disease, which affects children and adults, is currently unable to be prevented or cured.
Also, in order to manage T1D, people with the condition must constantly monitor their blood glucose levels, and manage those levels through insulin injection, activity, and diet in order to avoid life-threatening complications.
For a long time, it has been suggested, that the disease could be related to viral infection, which has lead some to propose the possibility of creating a vaccine for the disease.
With the impeding threat of the disease, researchers were pushed to search for a vaccine to combat the T1D. All around the globe, various countries has actively partake several studies and research. One of the country spearheading the research is Finland.
In Finland, researchers have been exploring this connection and potential vaccine for approximately 25 years. After such a laborious scientific journey, they believe they already found the viral group that can trigger T1D.
The long time effort of the team, they created a prototype vaccine which will move into human clinical trials by 2018.
As of the moment, it’s unlikely that the vaccine would become an immediate cure-all T1D, if the trials prove successful, it will dramatically shift the future of the disease.
As of posting, patients with T1D have been required to vigilantly self-manage. Complications of the disease, which can result when it goes undiagnosed or is ineffectively managed, can range from heart attack to stroke, amputation, kidney failure, and even blindness.
The team has issued a notes and disclaimer, they said the vaccine would not be a cure for T1D, but if it proves successful in preventing the onset of the condition, it could change the lives of millions of people around the world.